Pediatric NewsFDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024DermatologyGastroenterologyMusculoskeletal Disorders
Pediatric NewsPyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Rare DiseasesMusculoskeletal DisordersDermatologyGastroenterology
Pediatric NewsFDA Approves Polyarticular JIA Indication for SarilumabJune 12, 2024Rare DiseasesMusculoskeletal Disorders
Pediatric NewsFDA Grants New Pediatric Arthritis Indications for UpadacitinibJune 7, 2024Rare DiseasesMusculoskeletal DisordersGastroenterologyDermatology
Pediatric NewsMeasles Control So Far in 2024: ‘Not Off to a Great Start’March 25, 2024Infectious DiseasesVaccines
Pediatric NewsSecond FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous FormulationsMarch 8, 2024Rare DiseasesMusculoskeletal Disorders
Pediatric NewsOmalizumab for Food Allergies: What PCPs Should KnowMarch 4, 2024ImmunologyAtopic Dermatitis
Pediatric NewsFDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsDiabetesObesityBusiness of MedicineCardiologyEndocrinologyNeurology
Pediatric NewsFDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024GastroenterologyRare DiseasesMusculoskeletal DisordersDermatology
Pediatric NewsGlobal measles deaths increased by 43% in 2022December 7, 2023Infectious DiseasesVaccines
Pediatric NewsFDA warns of potentially lethal reaction to seizure medsNovember 29, 2023NeurologyDermatologyImmunologyMixed Topics
